Lifeloc Technologies, Inc.

Lifeloc Technologies, Inc.

LCTC
Lifeloc Technologies, Inc.US flagOther OTC
3.36
USD
- -
- -
9.25MMarket Cap
Lifeloc Technologies, Inc.
LCTC
(Other OTC)

Recent

price

3.36

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.59
3.42
2.82
3.47
3.84
3.6
3.42
3.26
3.44
3.57
2.59
2.87
3.46
3.8
3.35
3.3
3.29
Revenue per Share
0.17
0.32
0.2
0.24
0.25
0.12
0.18
0.01
0.09
0.26
-0.38
0.28
-0.19
0.08
-0.41
-0.9
-0.85
Basic EPS, GAAP
0.17
0.16
0.2
0.41
-0.12
0.2
0.24
-0.43
0.07
0.18
-0.57
-0.03
-0.07
-0.22
-0.79
-0.35
-0.36
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.77
-0.43
-0.23
- -
0.25
0.37
0.54
2.41
2.51
2.77
2.4
2.69
2.51
2.59
2.44
1.5
1.44
Book Value per Share
0.98
1.3
1.52
1.79
2.08
2.17
2.37
2.34
2.45
2.71
2.35
2.63
2.48
2.57
2.41
1.47
1.41
Tangible Book Value per Share
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
Basic Weighted Avg Shares
6
8
7
8
9
9
8
8
8
9
6
7
8
9
9
9
9
Sales/Revenue/Turnover
10.44
14.51
10.2
8.09
8.5
5.01
7.58
1.66
3.21
5.5
-18.18
-3.81
-7.67
-2.05
-16.49
-13.63
-11.91
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
Depreciation Expense
- -
1
- -
1
1
- -
- -
- -
- -
1
-1
1
- -
- -
-1
-2
-2
Net Income, GAAP
34.2
35.92
33.99
19.39
26.11
29.07
26.18
81.46
7.43
8.95
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
6.65
9.4
7
6.82
6.48
3.2
5.17
0.18
2.57
7.15
-14.5
9.58
-5.37
2.2
-12.33
-27.37
-25.77
Profit Margin (%)
2
3
3
4
4
4
5
4
4
5
4
5
5
5
4
3
3
Working Capital
- -
- -
- -
- -
2
1
1
1
1
1
1
1
1
1
2
2
2
LT Debt
2
3
4
4
5
5
6
6
6
7
6
7
6
6
6
4
4
Total Equity
- -
25.95
12.47
13.11
10.38
4.53
6.48
0.33
3.32
5.54
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
-54.38
-59.63
-207.9
55.74
14.4
18.34
0.51
3.67
8.62
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
193.03
37.28
38.86
0.4
3.59
9.66
-14.53
10.82
-7.15
3.29
-16.73
-47.83
-45.55
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
9
7
5

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
5
4
4
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
1
1
1
Inventories
3
3
3
Total Current Liabilities
1
1
1
Payables & Accruals
1
- -
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.76%
-5.55%
-34.09%
Free Cash Flow
-18.11%
89.12%
-52.3%
Net Income, GAAP
32.15%
-192.67%
134.62%
Sales/Revenue/Turnover
1.07%
7.69%
5.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
2
2
2
9
2025
2
2
2
2
9
2026
2
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.12
-0.12
-0.06
- -
-0.41
2025
-0.11
-0.14
-0.1
- -
-0.9
2026
-0.06
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Lifeloc Technologies, Inc. (OTC Pink: LCTC) develops, manufactures and markets portable hand-held and fixed-station evidential breath alcohol testers and related accessories, supplies and training programs for law enforcement, workplace testing, corrections, original equipment manufacturers and international customers worldwide; core products include fuel-cell-based breathalyzers such as the Phoenix 6.0, Lifeloc FC series, L-series LX9 and LT7 models, Sentinel zero-tolerance alcohol screening stations, R.A.D.A.R. real-time alcohol detection and reporting systems, EasyCal automatic calibration stations, alcohol simulation goggles, calibration products and consumables; the company also provides online drug-free workplace training, reasonable suspicion training, breath alcohol technician certification and urine collector training courses, as well as drug screening supplies. Founded in 1983 and headquartered in Wheat Ridge, Colorado, Lifeloc operates primarily in the United States with global distribution for its public safety and impairment detection solutions; it functions as a subsidiary of EDCO Partners LLLP and maintains a rentals segment for commercial real property. Recent developments include a $750,000 subordinated debenture financing from Diamond Bridge Capital LP in January 2025 to fund growth and R&D for SpinDx drug testing technology, which delivers point-of-care quantitative results in minutes at about $25 per test and targets Q4 2025 commercialization following in-house validation with Anschutz Medical Center samples and planned beta sites; in October 2025, the company entered a merger agreement to acquire Electronic Systems Technology Inc. (ELST) for $0.74 million, pending SEC review and shareholder approval, to expand international channels and product portfolio; Q3 2025 results showed nine-month revenues of $6.754 million amid prioritization of SpinDetect advancements.

Company News

APIChatGPT
  • Lifeloc Completes SpinDetect(TM) Disk Production Tooling, Commissions Cleanroom, and Outlines Staged Commercial Rollout

  • Lifeloc Reports First Quarter 2026 Results and SpinDetect(TM) Development Milestone

  • Lifeloc Reports 2025 Full Year Results

  • Lifeloc Reports Third Quarter 2025 Results

  • $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRTAF, LCTC, VACH, and EFIN

  • $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifeloc Technologies, Inc. (OTCMKTS: LCTC)

  • Lifeloc to Present at Emerging Growth Conference on September 25, 2025

  • Lifeloc Unveils SpinDetect(TM) Centrifugal Drug Analyzer at First Customer Demonstrations

  • Lifeloc Reports Second Quarter 2025 Results

  • Lifeloc Reports First Quarter 2025 Results

  • Lifeloc Technologies Reports 2024 Full Year Results

  • Lifeloc Technologies Secures $750,000 Financing to Support Growth and Innovation

  • Lifeloc Reports Third Quarter 2024 Results

  • Lifeloc Reports Second Quarter 2024 Results

  • Lifeloc Technologies, Inc. Appoints Adam Kashenberg to its Board of Directors

  • Lifeloc Technologies Reports First Quarter 2024 Results

  • Lifeloc Technologies Reports 2023 Full Year Results

  • Lifeloc Reports Third Quarter 2023 Results

  • Lifeloc Reports Second Quarter 2023 Results

  • Lifeloc Reports Second Quarter 2021 Results